Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Capra ME, Biasucci G, Banderali G, et al
Ischemic wounds treated with GHK-Cu show significantly decreased MMP2 and MMP9 concentrations compared to controls, accompanied by faster healing and reduced TNF-
These are one of, if not the most rigorously studied class of peptides ever, with many large, placebo-controlled, randomized trials that followed over the past twenty years from the original GLP-1 drugs such as exenatide, approved by the FDA in 2005
has been member on advisory boards or has consulted with AstraZeneca, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Menarini/Berlin Chemie, Merck, Sharp & Dohme, and NovoNordisk
Experimental findings indicate enhanced resistance of the mucosal lining to chemical or drug-induced injury, suggesting involvement in barrier maintenance and localized repair mechanisms
Note that tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
